Prevalence and correlates of fatigue in amyotrophic lateral sclerosis: A systematic review and meta-analysis.
ALS
Amyotrophic lateral sclerosis
Fatigue
Meta-analysis
Motor neuron disease
Non-motor symptoms
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
14 Oct 2023
14 Oct 2023
Historique:
received:
22
09
2023
accepted:
04
10
2023
medline:
15
10
2023
pubmed:
15
10
2023
entrez:
14
10
2023
Statut:
aheadofprint
Résumé
This systematic review and meta-analysis aimed to determine the frequency and correlates of fatigue in patients with amyotrophic lateral sclerosis (ALS). Three databases were searched up to 2nd May 2023 to identify studies reporting fatigue frequency in ALS. Studies included had to identify ALS patients through one of ALS diagnostic criteria and measure fatigue by a validated tool with a specific cut-off value. Meta-analysis was conducted using RStudio's "meta" package with a random-effects model. Subgroup analyses and meta-regression explored the relationship between fatigue frequency in ALS and different covariates. Eleven studies, compromising 1072 patients, met the inclusion criteria and were included in our analysis. The pooled frequency of fatigue across all studies was 48% (95% CI = 40% to 57%). Our subgroup analysis based on the ALSFRS-R revealed a higher frequency of fatigue in studies with lower scores (< 30) compared to those with higher scores (≥ 30), with a pooled frequency of 62% (95% CI = 43% to 79%) and 43% (95% CI = 37% to 49%), respectively. Also, the meta-regression analysis showed a significant negative association between fatigue and ALSFRS-R mean (P = 0.02). The included studies reported an association between fatigue and lower functional status and poorer quality of life in patients with ALS. Our findings suggest that fatigue is prevalent in almost half of ALS patients and is associated with lower functional status and poorer quality of life, highlighting the importance of assessing and managing fatigue in ALS patients.
Identifiants
pubmed: 37837507
doi: 10.1007/s10072-023-07119-7
pii: 10.1007/s10072-023-07119-7
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Hardiman O, Al-Chalabi A, Chio A et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Prim 3:17071. https://doi.org/10.1038/nrdp.2017.71
doi: 10.1038/nrdp.2017.71
pubmed: 28980624
Bettencourt C, Houlden H (2015) Exome sequencing uncovers hidden pathways in familial and sporadic ALS. Nat Neurosci 18:611–613. https://doi.org/10.1038/nn.4012
doi: 10.1038/nn.4012
pubmed: 25919956
Brown CA, Lally C, Kupelian V, Flanders WD (2021) Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants. Neuroepidemiology 55:342–353. https://doi.org/10.1159/000516752
doi: 10.1159/000516752
pubmed: 34247168
Sanjak M, Langford V, Holsten S et al (2017) Six-Minute Walk Test as a Measure of Walking Capacity in Ambulatory Individuals With Amyotrophic Lateral Sclerosis. Arch Phys Med Rehabil 98:2301–2307. https://doi.org/10.1016/j.apmr.2017.04.004
doi: 10.1016/j.apmr.2017.04.004
pubmed: 28465220
Hurwitz N, Radakovic R, Boyce E, Peryer G (2021) Prevalence of pain in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Front Degener 22:449–458. https://doi.org/10.1080/21678421.2021.1892765
doi: 10.1080/21678421.2021.1892765
Heidari ME, Nadali J, Parouhan A et al (2021) Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: A systematic review and meta-analysis. J Affect Disord 287:182–190. https://doi.org/10.1016/j.jad.2021.03.015
doi: 10.1016/j.jad.2021.03.015
pubmed: 33799036
Alencar MA, Guedes MCB, Pereira TAL et al (2022) Functional ambulation decline and factors associated in amyotrophic lateral sclerosis. Fisioter em Mov 35:1–10. https://doi.org/10.1590/fm.2022.35127
doi: 10.1590/fm.2022.35127
Kutlubaev MA, Caga J, Xu Y et al (2023) Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes. Amyotroph Lateral Scler Front Degener 24:14–23. https://doi.org/10.1080/21678421.2022.2053721
doi: 10.1080/21678421.2022.2053721
Lo Coco D, La Bella V (2012) Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol 19:760–763. https://doi.org/10.1111/j.1468-1331.2011.03637.x
doi: 10.1111/j.1468-1331.2011.03637.x
pubmed: 22233269
Gibbons C, Thornton E, Ealing J et al (2013) The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. Amyotroph Lateral Scler Front Degener 14:537–545. https://doi.org/10.3109/21678421.2013.799700
doi: 10.3109/21678421.2013.799700
Gibbons C, Pagnini F, Friede T, Young CA (2018) Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 1:1–33. https://doi.org/10.1002/14651858.CD011005.pub2
doi: 10.1002/14651858.CD011005.pub2
Ramirez C, Pimentel Piemonte ME, Callegaro D, Almeida Da Silva HC (2008) Fatigue in amyotrophic lateral sclerosis: Frequency and associated factors. Amyotroph Lateral Scler 9:75–80. https://doi.org/10.1080/17482960701642502
doi: 10.1080/17482960701642502
pubmed: 17924237
Siciliano M, Trojano L, Santangelo G et al (2018) Fatigue in Parkinson’s disease: A systematic review and meta-analysis. Mov Disord 33:1712–1723. https://doi.org/10.1002/mds.27461
doi: 10.1002/mds.27461
pubmed: 30264539
Oliva Ramirez A, Keenan A, Kalau O et al (2021) Prevalence and burden of multiple sclerosis-related fatigue: a systematic literature review. BMC Neurol 21:468. https://doi.org/10.1186/s12883-021-02396-1
doi: 10.1186/s12883-021-02396-1
pubmed: 34856949
pmcid: 8638268
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535–b2535. https://doi.org/10.1136/bmj.b2535
doi: 10.1136/bmj.b2535
pubmed: 19622551
pmcid: 2714657
Hamad AA (2023) Reconsidering the Need for De-Duplication Prior to Screening in Systematic Reviews. AlQ J Med Appl Sci 6:367–368. https://doi.org/10.5281/zenodo.8126972
doi: 10.5281/zenodo.8126972
Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan—a web and mobile app for systematic reviews. Syst Rev 5:210. https://doi.org/10.1186/s13643-016-0384-4
doi: 10.1186/s13643-016-0384-4
pubmed: 27919275
pmcid: 5139140
Munn Z, Moola S, Lisy K et al (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc 13:147–153. https://doi.org/10.1097/XEB.0000000000000054
doi: 10.1097/XEB.0000000000000054
pubmed: 26317388
Balduzzi S, Rücker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Heal 22:153–160. https://doi.org/10.1136/ebmental-2019-300117
doi: 10.1136/ebmental-2019-300117
Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634. https://doi.org/10.1136/bmj.315.7109.629
doi: 10.1136/bmj.315.7109.629
pubmed: 9310563
pmcid: 2127453
Andiappan K, Shahrizaila N, Abdul Latif L (2020) Disability profile and the factors affecting functional outcome in Malaysian motor neurone disease population. Neurol Asia 25:305–312
Jaafar N, Malek E, Ismail H, Salameh J (2021) Nonmotor Symptoms in Amyotrophic Lateral Sclerosis and Their Correlation With Disease Progression. J Clin Neuromuscul Dis 23:1–6. https://doi.org/10.1097/CND.0000000000000343
doi: 10.1097/CND.0000000000000343
pubmed: 34431795
Tiirola A, Korhonen T, Surakka T, Lehto JT (2017) End-of-Life Care of Patients With Amyotrophic Lateral Sclerosis and Other Nonmalignant Diseases. Am J Hosp Palliat Med 34:154–159. https://doi.org/10.1177/1049909115610078
doi: 10.1177/1049909115610078
Xu J, Nolan MT, Heinze K et al (2015) Symptom frequency, severity, and quality of life among persons with three disease trajectories: cancer, ALS, and CHF. Appl Nurs Res 28:311–315. https://doi.org/10.1016/j.apnr.2015.03.005
doi: 10.1016/j.apnr.2015.03.005
pubmed: 26608431
pmcid: 4661438
Yorkston K, Baylor C, Mach H (2017) Factors Associated With Communicative Participation in Amyotrophic Lateral Sclerosis. J Speech, Lang Hear Res 60:1791–1797. https://doi.org/10.1044/2017_JSLHR-S-16-0206
doi: 10.1044/2017_JSLHR-S-16-0206
pubmed: 28655040
Zizzi C, Seabury J, Rosero S et al (2023) Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): a national, cross-sectional study. eClinicalMedicine 55:1–12. https://doi.org/10.1016/j.eclinm.2022.101768
doi: 10.1016/j.eclinm.2022.101768
Smith LD, Kenny CE, Ringel SP, Neville HE (1988) Motor neuron disease in the Rocky Mountain region. West J Med 148:430–432
pubmed: 3388845
pmcid: 1026132
Brizzi KT, Bridges JFP, Yersak J et al (2020) Understanding the needs of people with ALS: a national survey of patients and caregivers. Amyotroph Lateral Scler Front Degener 21:355–363. https://doi.org/10.1080/21678421.2020.1760889
doi: 10.1080/21678421.2020.1760889
Hirayama T, Shibukawa M, Yanagihashi M et al (2022) Investigation of non-motor symptoms in patients with amyotrophic lateral sclerosis. Acta Neurol Belg. https://doi.org/10.1007/s13760-022-02036-6
doi: 10.1007/s13760-022-02036-6
pubmed: 35987973
pmcid: 10505101
Maessen M, Veldink JH, Berg LH et al (2010) Requests for euthanasia: origin of suffering in ALS, heart failure, and cancer patients. J Neurol 257:1192–1198. https://doi.org/10.1007/s00415-010-5474-y
doi: 10.1007/s00415-010-5474-y
pubmed: 20148336
Nicholson K, Murphy A, McDonnell E et al (2018) Improving symptom management for people with amyotrophic lateral sclerosis. Muscle Nerve 57:20–24. https://doi.org/10.1002/mus.25712
doi: 10.1002/mus.25712
pubmed: 28561886
Chowdhury A, Mukherjee A, Sinharoy U et al (2021) Non-motor features of amyotrophic lateral sclerosis: A clinic-based study. Ann Indian Acad Neurol. https://doi.org/10.4103/aian.AIAN_51_21
doi: 10.4103/aian.AIAN_51_21
pubmed: 35002134
pmcid: 8680894
Vucic S, Krishnan AV, Kiernan MC (2007) Fatigue and activity dependent changes in axonal excitability in amyotrophic lateral sclerosis. J Neurol Neurosurg & Psychiatry 78:1202–1208. https://doi.org/10.1136/jnnp.2006.112078
doi: 10.1136/jnnp.2006.112078
Sanjak M, Brinkmann J, Belden D et al (2001) Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. J Neurol Sci 191:55–59. https://doi.org/10.1016/S0022-510X(01)00624-4
doi: 10.1016/S0022-510X(01)00624-4
pubmed: 11676992
Sandstedt P, Littorin S, Johansson S et al (2018) Disability and Contextual Factors in Patients with Amyotrophic Lateral Sclerosis - A Three-Year Observational Study. J Neuromuscul Dis 5:439–449. https://doi.org/10.3233/JND-180322
doi: 10.3233/JND-180322
pubmed: 30282373
pmcid: 6218138
Vogt S, Schreiber S, Pfau G et al (2020) Dyspnea as a Fatigue-Promoting Factor in ALS and the Role of Objective Indicators of Respiratory Impairment. J Pain Symptom Manage 60:430-438.e1. https://doi.org/10.1016/j.jpainsymman.2020.02.021
doi: 10.1016/j.jpainsymman.2020.02.021
pubmed: 32145336
Alencar MA, Soares BL, de Rangel MF, A, et al (2022) Fatigue in amyotrophic lateral sclerosis and correlated factors. Arq Neuropsiquiatr 80:1045–1051. https://doi.org/10.1055/s-0042-1758563
doi: 10.1055/s-0042-1758563
pubmed: 36535289
pmcid: 9770075
An R, Wu Y, Li Y et al (2022) Pain-Related Factors and Their Impact on Quality of Life in Chinese Patients With Amyotrophic Lateral Sclerosis. Front Neurosci 16:1–8. https://doi.org/10.3389/fnins.2022.897598
doi: 10.3389/fnins.2022.897598
An R, Li C, Li X et al (2022) Fatigue in Chinese Patients With Amyotrophic Lateral Sclerosis: Associated Factors and Impact on Quality of Life. Front Neurol 13:1–8. https://doi.org/10.3389/fneur.2022.806577
doi: 10.3389/fneur.2022.806577
McElhiney MC, Rabkin JG, Gordon PH et al (2009) Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry 80:1146–1149. https://doi.org/10.1136/jnnp.2008.163246
doi: 10.1136/jnnp.2008.163246
pubmed: 19762902
Panitz S, Kornhuber M, Hanisch F (2015) The checklist individual strength (CIS20-R) in patients with amyotrophic lateral sclerosis - A longitudinal study. Acta Neurol Scand 131:372–380. https://doi.org/10.1111/ane.12349
doi: 10.1111/ane.12349
pubmed: 25639482
Raheja D, Stephens HE, Lehman E et al (2016) Patient-reported problematic symptoms in an ALS treatment trial. Amyotroph Lateral Scler Front Degener 17:198–205. https://doi.org/10.3109/21678421.2015.1131831
doi: 10.3109/21678421.2015.1131831
Sandstedt P, Johansson S, Ytterberg C et al (2016) Predictors of health-related quality of life in people with amyotrophic lateral sclerosis. J Neurol Sci 370:269–273. https://doi.org/10.1016/j.jns.2016.09.034
doi: 10.1016/j.jns.2016.09.034
pubmed: 27772773
Groenestijn AC, Schröder CD, Kruitwagen-Van Reenen ET et al (2017) Participation restrictions in ambulatory amyotrophic lateral sclerosis patients: Physical and psychological factors. Muscle Nerve 56:912–918. https://doi.org/10.1002/mus.25574
doi: 10.1002/mus.25574
pubmed: 28073181
Goldstein L, Atkins L, Leigh P (2002) Correlates of Quality of Life in people with motor neuron disease (MND). Amyotroph Lateral Scler Other Mot Neuron Disord 3:123–129. https://doi.org/10.1080/146608202760834120
doi: 10.1080/146608202760834120
Chaudhuri A, Behan PO (2004) Fatigue in neurological disorders. Lancet 363:978–988. https://doi.org/10.1016/S0140-6736(04)15794-2
doi: 10.1016/S0140-6736(04)15794-2
pubmed: 15043967
Chiò A, Canosa A, Calvo A et al (2021) Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis. Expert Rev Neurother 21:1419–1440. https://doi.org/10.1080/14737175.2021.1984883
doi: 10.1080/14737175.2021.1984883
pubmed: 34554894
Krupp LB (1989) The Fatigue Severity Scale. Arch Neurol 46:1121. https://doi.org/10.1001/archneur.1989.00520460115022
doi: 10.1001/archneur.1989.00520460115022
pubmed: 2803071
Vercoulen JHMM, Swanink CMA, Fennis JFM et al (1994) Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38:383–392. https://doi.org/10.1016/0022-3999(94)90099-X
doi: 10.1016/0022-3999(94)90099-X
pubmed: 7965927
Simmons Z, Felgoise SH, Bremer BA et al (2006) The ALSSQOL: Balancing physical and nonphysical factors in assessing quality of life in ALS. Neurology 67:1659–1664. https://doi.org/10.1212/01.wnl.0000242887.79115.19
doi: 10.1212/01.wnl.0000242887.79115.19
pubmed: 17101900
Cumming TB, Packer M, Kramer SF, English C (2016) The prevalence of fatigue after stroke: A systematic review and meta-analysis. Int J Stroke 11:968–977. https://doi.org/10.1177/1747493016669861
doi: 10.1177/1747493016669861
pubmed: 27703065
Alghamdi I, Ariti C, Williams A et al (2021) Prevalence of fatigue after stroke: A systematic review and meta-analysis. Eur Stroke J 6:319–332. https://doi.org/10.1177/23969873211047681
doi: 10.1177/23969873211047681
pubmed: 35342803
pmcid: 8948505
Simmons Z (2015) Patient-Perceived Outcomes and Quality of Life in ALS. Neurotherapeutics 12:394–402. https://doi.org/10.1007/s13311-014-0322-x
doi: 10.1007/s13311-014-0322-x
pubmed: 25502407
Majmudar S, Wu J, Paganoni S (2014) Rehabilitation in amyotrophic lateral sclerosis: Why it matters. Muscle Nerve 50:4–13. https://doi.org/10.1002/mus.24202
doi: 10.1002/mus.24202
pubmed: 24510737
pmcid: 4433000
Heckman BW, Mathew AR, Carpenter MJ (2015) Treatment burden and treatment fatigue as barriers to health. Curr Opin Psychol 5:31–36. https://doi.org/10.1016/j.copsyc.2015.03.004
doi: 10.1016/j.copsyc.2015.03.004
pubmed: 26086031
pmcid: 4465180